Marina W. Delpin

Marina W. Delpin

Auto-generated profile, based on publicly available information

Marina W. Delpin

Environment Institute, Adelaide University, Adelaide, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2016 in Frontiers in Microbiology
Verified
Journal Article
Open access
MTMariane Schmidt Thøgersen
Mariane Schmidt Thøgersen
MDMarina W. Delpin
Marina W. Delpin
JMJette Melchiorsen
Jette Melchiorsen
MKMogens Kilstrup
Mogens Kilstrup
MMMaria Månsson
Maria Månsson
LGLone Gram
Lone Gram
It has previously been reported that some strains of the marine bacterium Pseudoalteromonas luteoviolacea produce the purple bioactive pigment violacein as well as the antibiotic compound indolmycin, hitherto only found in Streptomyces. The purpose of the present study was to determine the relative role of each of these two compounds as antibacterial compounds in P. luteoviolacea S4054. Using Tn10 transposon mutagenesis, a mutant strain that was significantly reduced in violacein production in mannose-containing substrates was created. Full genome analyses revealed that the vio-biosynthetic gene cluster was not interrupted by the transposon; instead the insertion was located to the maeA gene encoding the malic enzyme. Supernatant of the mutant strain inhibited Vibrio anguillarum and Staphylococcus aureus in well diffusion assays and in MIC assays at the same level or even more pronounced as the wild type strain. The mutant strain killed V. anguillarum in co-culture experiments as efficiently as the wild type. Using UHPLC-UV/Vis analyses, we quantified violacein and indolmycin, and the mutant strain only produced 7-10% the amount of violacein compared to the wildtype strain. In contrast, the amount of indolmycin produced by the mutant strain was about 300% that of the wildtype. Since inhibition of V. anguillarum and S. aureus by the mutant strain was similar to that of the wild type, it is concluded that violacein is not the major antibacterial compound in P. luteoviolacea. We furthermore propose that production of violacein and indolmycin may be metabolically linked and that yet unidentified antibacterial compound(s) may be play a role in the antibacterial activity of P. luteoviolacea.

1 February 2016 in Journal of Biotechnology
Verified
Journal Article
Closed access
JPJames S. Paterson
James S. Paterson
SOSamuel Ogden
Samuel Ogden
RSRenee J. Smith
Renee J. Smith
MDMarina W. Delpin
Marina W. Delpin
JMJames G. Mitchell
James G. Mitchell
Jamie QuintonJamie Quinton
Jamie Quinton

11 May 2026 in Nature Sustainability
Verified
Journal Article
Closed access
PDF file
AKAnna M. Kotarba-Morley
Anna M. Kotarba-Morley
SWSeth Westra
Seth Westra
GAGregory Andrews
Gregory Andrews
DBDouglas Bardsley
Douglas Bardsley
FBFran Baum
Fran Baum
ALAndrew Lowe
Andrew Lowe